![](/img/cover-not-exists.png)
Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
Lutgens, Esther, Seijkens, Tom T.P.Volume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/jitc-2019-000300
Date:
February, 2020
File:
PDF, 175 KB
2020